While chemotherapy increased the gene expression of ABCC3, knocking down ABCC3 increased DOX retention in breast cancer cells and the sensitivity and susceptibility to the DOX and several other cytotoxic anti-neoplastic agents (mitoxantrone and methotrexate) [190]. This evidence concerns the gene ABCC3 and breast cancer.